Skip to main content
SpringerLink
Log in

Postpartum Hypertension

  • Preeclampsia (VD Garovic, Section Editor)
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Hypertension affects approximately 10% of pregnancies and may persist in the postpartum period. Furthermore, de novo hypertension may present after delivery, but its exact prevalence is not verified. Both types of hypertension expose the mother to eventually severe complications like eclampsia, stroke, pulmonary edema, and HELLP (hemolysis, elevated liver enzymes, low platelet) syndrome.

Recent Findings

Until today, there are limited data regarding the risk factors, pathogenesis, and pathophysiology of postpartum hypertensive disorders. However, there is certain evidence that preeclampsia may in large part be responsible. Women who experienced preeclampsia during pregnancy, although considered cured after delivery and elimination of the placenta, continue to present endothelial and renal dysfunction in the postpartum period. The brain and kidneys are particularly sensitive to this pathological vascular condition, and severe complications may result from their involvement.

Summary

Large randomized trials are needed to give us the evidence that will allow a timely diagnosis and treatment. Until then, medical providers should increase their knowledge regarding hypertension after delivery because many times there is an underestimation of the complications that can ensue after a misdiagnosed or undertreated postpartum hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. American College of Obstetricians and Gynecologists: TaskForce on Hypertension in Pregnancy.Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122–31.

    Google Scholar 

  2. Goel A, Maski M, Baijracharva S, Wenger J, Zhang D,Salahuddin S. Epidemiology and mechanisms of de novo and persistent hypertension in the postpartum period. Circulation. 2015; 132(18): 1726–1733 doi:https://doi.org/10.1161/CIRCULATIONAHA. . 115.015721.

  3. Magee L, von Dadelszen P. Prevention and treatment of postpartum hypertension. Cochrane Database Syst Rev. 2013;4:CD004351.

    Google Scholar 

  4. Sibai BM. Etiology and management of postpartum hypertension-preeclampsia. Am J Obstet Gynecol. 2012;206:470–5. https://doi.org/10.1016/j.ajog.2011.09.002.

    Article  PubMed  Google Scholar 

  5. Poon LC, Kametas NA, Chelemen T, Leal A, Nicolaides KH. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens. 2010;24(2):104–10. https://doi.org/10.1038/jhh.2009.45.

    Article  CAS  PubMed  Google Scholar 

  6. Saudan P, Brown MA, Buddle ML, Jones M. Does gestational hypertension become pre-eclampsia? Br J Obstet Gynaecol. 1998;105(11):1177–84.

    CAS  PubMed  Google Scholar 

  7. Shen M, Smith GN, Rodger M, White RR, Walker MC, Wen SW. Comparison of risk factors and outcomes of gestational hypertension and pre-eclampsia. PLoS One. 2017;12:e0175914.

    PubMed  PubMed Central  Google Scholar 

  8. Chelsey LC. Blood pressure, edema and proteinuria in pregnancy.9 .Proposal for classification. Prog Clin Biol Res. 1976;7:249–68.

    Google Scholar 

  9. Podymow T, August P. Postpartum course of gestational hypertension and preeclampsia. Hypertens Pregnancy. 2010;29:294–300. https://doi.org/10.3109/10641950902777747.

    Article  PubMed  Google Scholar 

  10. Kuklina EV, Tong X, Bansil P, George MG, Callaghan WM. Trends in pregnancy hospitalizations that included a stroke in the United States from 1994 to 2007: reasons for concern? Stroke. 2011;42:2564–70. https://doi.org/10.1161/STROKEAHA.110.610592.

    Article  PubMed  Google Scholar 

  11. Maski AM, Baijracharva S, Wenger J, Zhang D, Salahuddin S. Epidemiology and mechanisms of de novo and persistent hypertension in the postpartum period. Circulation. 2015 November 3;132(18):1726–33. https://doi.org/10.1161/CIRCULATIONAHA.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Kamel H, Navi BB, Sriram N, Hovsepian DA, Devereux RB, Elkind MS Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med 2014;370:1307–1315. doi: https://doi.org/10.1056/NEJMoa1311485.

  13. Miller EC, Gatollari HJ, Too G, et al. Risk of pregnancy-associated stroke across age groups in New York State. JAMA Neurol. 2016;73(12):1461–7. https://doi.org/10.1001/jamaneurol.2016.3774.

    Article  PubMed  Google Scholar 

  14. Miller EC, Yaghi S, Boehme AK, Willey JZ, Elkind MS, Marshall RS. Mechanisms and outcomes of stroke during pregnancy and the postpartum period: a cross-sectional study. Neurol Clin Pract. 2016;6(1):29–39.

    PubMed  PubMed Central  Google Scholar 

  15. van Veen TR, Panerai RB, Haeri S, Griffioen AC, Zeeman GG, Belfort MA. Cerebral autoregulation in normal pregnancy and preeclampsia. Obstet Gynecol. 2013;122(5):1064–9.

    PubMed  Google Scholar 

  16. Hammer ES, Cipolla MJ. Cerebrovascular dysfunction in preeclamptic pregnancies. Curr Hypertens Rep. 2015;17(8):64.

    PubMed  PubMed Central  Google Scholar 

  17. Sanghavi M, Rutherford JD. Cardiovascular physiology of pregnancy. Circulation. 2014;130:1003–8.

    PubMed  Google Scholar 

  18. Mahendru AA, Everett TR, Wilkinson IB, Lees CC, McEniery CM. A longitudinal study of maternal cardiovascular function from preconception to the postpartum period. J Hypertens. 2014;32:849–56.

    CAS  PubMed  Google Scholar 

  19. Robson SC, Hunter S, Moore M, Dunlop W. Haemodynamic changes during the puerperium: a Doppler and M-mode echocardiographic study. Br J Obstet Gynaecol. 1987;94:1028–39.

    CAS  PubMed  Google Scholar 

  20. Hunter S, Robson SC. Adaptation of the maternal heart in pregnancy. Br Heart J. 1992;68:540–3.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Cheung KL, Lafayette RA. Renal physiology of pregnancy. Adv Chronic Kidney Dis. 2013;20:209–14.

    PubMed  PubMed Central  Google Scholar 

  22. Berkane N, Liere P, Oudinet JP, Hertig A, Lefèvre G, Pluchino N, et al. From pregnancy to preeclampsia: a key role for estrogens. Endocr Rev. 2017;38(2):123–44.

    PubMed  Google Scholar 

  23. Conrad KP. Maternal vasodilation in pregnancy: the emerging role of relaxin. Am J Phys Regul Integr Comp Phys. 2011;301(2):R267–75.

    CAS  Google Scholar 

  24. . Kodogo V, Azibani F and Sliwa K. Role of pregnancy hormones and hormonal interaction on the maternal cardiovascular system: a literature review. Clin Res Cardiol. Epub ahead of print 26 February 2019. DOI: https://doi.org/10.1007/s00392-01901441-x

  25. Conrad KP. Emerging role of relaxin in the maternal adaptations to normal pregnancy: implications for preeclampsia. Semin Nephrol. 2011;31:15–32.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Fisher C, MacLean M, Morecroft I, Seed A, Johnston F, Hillier C, et al. Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart? Circulation. 2002;106:292–5.

    CAS  PubMed  Google Scholar 

  27. O’sullivan KP, Marshall SA, Cullen S, Saunders T, Hannan NJ, Senadheera SN, et al. Evidence of proteinuria, but no other characteristics of pre-eclampsia, in relaxin-deficient mice. Reprod Fertil Dev. 2017;29:1477–85. https://doi.org/10.1071/RD16056.

    Article  CAS  PubMed  Google Scholar 

  28. Marshall SA, Leo CH, Senadheera SN, Girling JE, Tare M, Parry LJ. Relaxin deficiency attenuates pregnancy-induced adaptation of the mesenteric artery to angiotensin II in mice. Am J Physiol Regul Integr Comp. 2016a;310:R847–57. https://doi.org/10.1152/ajpregu.00506.2015Physiol.

    Article  Google Scholar 

  29. Mirabito Colafella KM, Samuel CS, Denton KM. Relaxin contributes to the regulation of arterial pressure in adult female mice. Clin Sci. 2017;131:2795–805. https://doi.org/10.1042/CS20171225.

    Article  CAS  Google Scholar 

  30. Gooi, J. H., Richardson, M. L., Jelinic, M., Girling, J. E., Wlodek, M. E., Tare, M., et al. (2013). Enhanced uterine artery stiffness in aged pregnant relaxin mutant mice is reversed with exogenous relaxin treatment. 89:18. Biol. Reprod doi: https://doi.org/10.1095/biolreprod.113.108118.

  31. Mirabito Colafella KM, Samuel CS, Denton KM. Relaxin contributes to the regulation of arterial pressure in adult female mice. Clin Sci. 2017;131:2795–805. https://doi.org/10.1042/CS20171225.

    Article  CAS  Google Scholar 

  32. Lumbers ER, Pringle KG. Roles of the circulating renin angiotensin- aldosterone system in human pregnancy. Am J Phys Regul Integr Comp Phys. 2014;306(2):R91–R101.

    CAS  Google Scholar 

  33. August P, Lindheimer MD. Pathophysiology of preeclampsia. Hypertension. 1995;142:2407–26.

    Google Scholar 

  34. Chesley LC. Hypertensive disorders in pregnancy. New York: Appleton-Century-Crofts; 1978.

    Google Scholar 

  35. Lindheimer MD, Katz AI. Renal physiology and disease in pregnancy. In: Seldin DW, Giebisch G, editors. The kidney: physiology and pathophysiology. 2nd ed. New York: Raven Press; 1992. p. 3371–431.

    Google Scholar 

  36. Granger JP, Alexander BT, Bennett WA, et al. Pathophysiology of pregnancy-induced hypertension. Am J Hypertens. 2001;14:178S–85S.

    CAS  PubMed  Google Scholar 

  37. Redman CW, Staff AC. Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity. Am J Obstet Gynecol. 2015;213(4 Suppl):S9.e1–S9–S11.

    CAS  Google Scholar 

  38. Maloney KF, Heller D, Baergen RN. Types of maternal hypertensive disease and their association with pathologic lesions and clinical factors. Fetal Pediatr Pathol. 2012;31:319–23.

    PubMed  Google Scholar 

  39. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol. 2012;206:58–e1–8.

    PubMed  Google Scholar 

  40. Ghuman N, Rhiener J, Tendler BE, White WB. Hypertension in the postpartum woman: clinical update for the hypertension specialist. J Clin Hypertens (Greenwich). 2009;11:726–33.

    CAS  Google Scholar 

  41. Makris A, Thornton C, Hennessy A. Postpartum hypertension and nonsteroidal analgesia. Am J Obstet Gynecol. 2004;190:577–8.

    PubMed  Google Scholar 

  42. Makkonen N, Harju M, Kirkinen P. Postpartum recovery after severe pre-eclampsia and HELLP-syndrome. J Perinat Med. 1996;24:641–9.

    CAS  PubMed  Google Scholar 

  43. Berks D, Steegers EA, Molas M, Visser W. Resolution of hypertension and proteinuria after preeclampsia. Obstet Gynecol. 2009;114:1307–14.

    PubMed  Google Scholar 

  44. Suzuki H, Watanabe Y, Arima H, Kobayashi K, Ohno Y, Kanno Y. Short- and long-term prognosis of blood pressure and kidney disease in women with a past history of preeclampsia. Clin Exp Nephrol. 2008;12:102–9.

    PubMed  Google Scholar 

  45. Walters BNJ, Thompson ME, Lee A, de Swiet M. Blood pressure in the puerperium. Clin Sci (Colch). 1986;71:589–94.

    CAS  Google Scholar 

  46. Ferrazzani S, De Carolis S, Pomini F, Testa AC, Mastromarino C, Caruso A. The duration of hypertension in the puerperium of preeclamptic women: relationship with renal impairment and week of delivery. Am J Obstet Gynecol. 1994;17:506–12.

    Google Scholar 

  47. Clark SL, Belfort MA, Dildy GA, et al. Emergency department use during the postpartum period: implications for current management of the puerperium. Am J Obstet Gynecol. 2010;203:38–e1–6.

    PubMed  Google Scholar 

  48. Matthys LA, Coppage KH, Lambers DS, Barton JR, Sibai BM. Delayed postpartum pre- eclampsia: an experience of 151 cases. Am J Obstet Gynecol. 2004;190:1464–6.

    PubMed  Google Scholar 

  49. Hargood JL, Brown MA. Pregnancy-induced hypertension: recurrence rate in second pregnancies. Med J Aust. 1991;154:376–7.

    CAS  PubMed  Google Scholar 

  50. Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation. 2010;122:478–87.

    CAS  PubMed  Google Scholar 

  51. Silver HM, Seebeck M, Carlson R. Comparison of total blood volume in normal, preeclamptic, and nonproteinuric gestational hypertensive pregnancy by simultaneous measurement of red blood cell and plasma volumes. Am J Obstet Gynecol. 1998;179:87–93.

    CAS  PubMed  Google Scholar 

  52. Ohashi Y, Ibrahim H, Furtado L, Kingdom J, Carvalho JC. Non-invasive hemodynamic assessment of non-pregnant, healthy pregnant and preeclamptic women using bioreactance. [corrected]. Rev Bras Anestesiol. 2010;60:603–13 335–40.

    PubMed  Google Scholar 

  53. Ditisheim A, Wuerzner G, Ponte B, Vial Y, Irion O, Burnier M, et al. Prevalence of hypertensive phenotypes after preeclampsia: a prospective cohort study. Hypertension. 2018;71:103–9.

    CAS  PubMed  Google Scholar 

  54. Martillotti G, Ditisheim A, Burnier M, Wagner G, Boulvain M, Irion O, et al. Increased salt sensitivity of ambulatory blood pressure in women with a history of severe preeclampsia. Hypertension. 2013;62:802–8. https://doi.org/10.1161/HYPERTENSIONAHA.113.01916.

    Article  CAS  PubMed  Google Scholar 

  55. Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension. 2001;37(2 pt 2):429–32.

    CAS  PubMed  Google Scholar 

  56. Morimoto A, Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S, et al. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet. 1997;350:1734–7. https://doi.org/10.1016/S0140-6736(97)05189-1.

    Article  CAS  PubMed  Google Scholar 

  57. Fujii T, Uzu T, Nishimura M, Takeji M, Kuroda S, Nakamura S, et al. Circadian rhythm of natriuresis is disturbed in nondipper type of essential hypertension. Am J Kidney Dis. 1999;33:29–35.

    CAS  PubMed  Google Scholar 

  58. Benschop L, Duvekot JJ, Versmissen J, van Broekhoven V, Steegers E, Roeters van Lennep J Blood pressure profile 1 year after severe preeclampsia. Hypertension. 2018 Mar;71(3):491–498. doi: https://doi.org/10.1161/HYPERTENSIONAHA.117.10338.

  59. Reiter L, Brown MA, Whitworth JA. Hypertension in pregnancy: the incidence of underlying renal disease and essential hypertension. Am J Kidney Dis. 1994;24:883–7.

    CAS  PubMed  Google Scholar 

  60. Tan L-K, De Swiet M. The management of postpartum hypertension. BJOG Int J Obstet Gynaecol. 2002;109:733–6. https://doi.org/10.1111/j.1471-0528.2002.01012.x.

    Article  Google Scholar 

  61. Stagnaro-Green A. Postpartum thyroiditis. J Clin Endocrinol Metab. 2002;87:4042–7.

    CAS  PubMed  Google Scholar 

  62. Wuytack F, Smith V, Cleary BJ. Oral non-steroidal anti-inflammatory drugs (single dose) for perineal pain in the early postpartum period. The Cochrane Database of Systematic Reviews 2016, Issue 7. Art. No.:CD011352.

  63. Snowden S, Nelson R. The effects of nonsteroidal anti-inflammatory drugs on blood pressure in hypertensive patients. Cardiol Rev. 2011;19:184–91.

    PubMed  Google Scholar 

  64. Johnson AG, Nguen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med. 1994;121:289–300.

    CAS  PubMed  Google Scholar 

  65. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev. 1999;79:1193–226.

    CAS  PubMed  Google Scholar 

  66. Palmer BF. Renal complications associated with use of nonsteroidal anti-inflammatory agents. J Investig Med. 1995;43:516–33.

    CAS  PubMed  Google Scholar 

  67. Executive summary: hypertension in pregnancy. American College of Obstreticians and Gynecologists. Obstet Gynecol 2013;122:1122–1131, Hypertension in Pregnancy.

  68. Oscar A, Viteri MD, Joey A, England MD, Mesk A, Alrais MD, et al. Association of nonsteroidal antiinflammatory drugs and postpartum hypertension in women with preeclampsia with severe fatures. Obstet Gynecol. 2017;130(4):830–5.

    Google Scholar 

  69. Blue NR, Murray-Krezan C, Drake-Lavelle S, Weinberg D, Holbrook BD, Katukuri VR, et al. Effect of ibuprofen vs acetaminophen on postpartum hypertension in preeclampsia with severe features: a double-masked, randomized controlled trial. Am J Obstet Gynecol. 2018;218(6):616–e1–616.e8.

    CAS  PubMed  PubMed Central  Google Scholar 

  70. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Preeclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974.

    PubMed  PubMed Central  Google Scholar 

  71. Felder RA, White MJ, Williams SM, Jose PA. Diagnostic tools for hypertension and salt sensitivity testing. Curr Opin Nephrol Hypertens. 2013;22:65–76.

    CAS  PubMed  PubMed Central  Google Scholar 

  72. Schulman IH, Aranda P, Raij L, Veronesi M, Aranda FJ, Martin R. Surgical menopause increases salt sensitivity of blood pressure. Hypertension. 2006;47:1168–74.

    CAS  PubMed  Google Scholar 

  73. Vikse B, Irgens L, Leivestad T, Skjaerven R, Iversen B. Pre-eclampsia and the risk of end-stage kidney disease. N Engl J Med. 2008;359:800–9.

    CAS  PubMed  Google Scholar 

  74. Saxena AR, Karumanchi SA, Brown NJ, Royle CM, McElrath TF, Seely EW. Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy. Hypertension. 2010;55:1239–45.

    CAS  PubMed  Google Scholar 

  75. Khalil AA, Tsikas D, Akolekar R, Jordan J, Nicolaides KH. Asymmetric dimethylarginine, arginine and homoarginine at 11-13 weeks’ gestation and preeclampsia: a case-control study. J Hum Hypertens. 2013;27:38–43.

    CAS  PubMed  Google Scholar 

  76. Walters BNJ, Thompson ME, Lee A, de Swiet M. Blood pressure in the puerperium. Clin Sci. 1986;71:589–94.

    CAS  Google Scholar 

  77. Därr R, Lenders JW, Hofbauer LC, Naumann B, Bornstein SR, Eisenhofer G. Pheochromocytoma - update on disease management. Ther Adv Endocrinol Metab. 2012;3(1):11–26. https://doi.org/10.1177/2042018812437356.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Webster J, Koch HF. Aspects of tolerability of centrally acting antihypertensive drugs. J Cardiovasc Pharmacol. 1996;27(Suppl):S49–54.

    CAS  PubMed  Google Scholar 

  79. Kelsey, Julie J.. “Drug principles in lactation.” (2016).

  80. American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108:776–89.

    Google Scholar 

  81. Magee LA, Miremadi S, Li J, Cheng C, Ensom M, Carleton B, et al. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol. 193(1):153–63.

  82. O’Donnell MJ, Yusuf S, Mente A, Gao P, Mann JF, Teo K, et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA. 2011;306:2229–38.

    PubMed  Google Scholar 

  83. Burnier M, Phan O, Wang Q. High salt intake: a cause of blood pressure-independent left ventricular hypertrophy? Nephrol Dial Transplant. 2007;22:2426–9.

    PubMed  Google Scholar 

  84. Aoki H, Ito N, Kaniwa N, Saito Y, Wada Y, Nakajima K, et al. Low levels of amlodipine in breast milk and plasma. Breastfeed Med. 2018 Nov;13(9):622–6. https://doi.org/10.1089/bfm.2018.0158Epub 2018 Sep 28.

  85. Liedholm H, Melander A, Bitzen PO, Lonnerholm G, Mattiasson I, Wilsson B, et al. Accumulation of atenolol and metoprolol in human breast. Milk.Eur J Clin Pharmacol. 1981;20:229–31.

    CAS  Google Scholar 

  86. Shannon ME, Malecha SE, Cha AJ. Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) and lactation: an update. J Hum Lact. 2000;16:152–5.

    CAS  PubMed  Google Scholar 

  87. Healy M. Suppressing lactation with oral diuretics. Lancet. 1961;277:1353–4.

    Google Scholar 

  88. Vigil-de Gracia P, Ruiz E, Lσpez JC, et al. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial. Hypertens Preg nancy. 2007;26:163–71.

    CAS  Google Scholar 

  89. Vermillion ST, Scardo JA, Newman RB, Chauhan SP Chauhan SP.A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy. Am J Obstet Gynecol 1999;181:858–861.

  90. Raheem IA, Saaid R, Omar SZ, Tan PC. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial. BJOG. 2012;119:78–85.

    CAS  PubMed  Google Scholar 

  91. Sharma KJ, Greene N, Kilpatrick SJ. Oral labetalol compared to oral nifedipine for postpartum hypertension: a randomized controlled trial. Hypertension in Pregnancy. 2017;36(1):44–7. https://doi.org/10.1080/10641955.2016.1231317.

    Article  CAS  PubMed  Google Scholar 

  92. Vigil-de Gracia P, Ludmir J. The use of magnesium sulfate for women with severe preeclampsia or eclampsia diagnosed during the postpartum period. J Matern Fetal Neonatal Med. 2015;28:2207–9.

    PubMed  Google Scholar 

  93. Vigil-De Gracia P, Ramirez R, Durán Y, Quintero A. Magnesium sulfate for 6 vs 24 hours post delivery in patients who received magnesium sulfate for less than 8 hours before birth: a randomized clinical trial. BMC Pregnancy Childbirth. 2017;17(1):241. Published 2017 Jul 24. doi:https://doi.org/10.1186/s12884-017-1424-3

Download references

Author information

Authors and Affiliations

  1. Cardiology Department, Hippokration Hospital, Athens, Greece

    V. Katsi

  2. Department of Cardiology, Helena Venizelou Hospital, Athens, Greece

    G. Skalis, G. Vamvakou & T. Makris

  3. 1st Department of Cardiology, National and Kapodistrian University of Athens, Athens, Greece

    D. Tousoulis

Authors
  1. V. Katsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Skalis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Vamvakou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Tousoulis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Makris
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Skalis.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Preeclampsia

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Katsi, V., Skalis, G., Vamvakou, G. et al. Postpartum Hypertension. Curr Hypertens Rep 22, 58 (2020). https://doi.org/10.1007/s11906-020-01058-w

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11906-020-01058-w

Keywords

Search

Navigation